Ironwood Pharmaceuticals (IRWD) executive compensation, 2026 proxy

Thomas McCourt, Chief Executive Officer, was paid $1.9M in 2025, down 68% from $6.1M the year before.

Filed
April 28, 2026
Annual meeting
June 16, 2026
Pay year
2025
Named executives
3
CEO total pay
$1.9M-68% vs prior year
CEO pay in equity
21%$411,696 in awards
Prior say-on-pay support
96%of votes cast
Say-on-pay support
96%Prior year vote

How McCourt was paid

$1.9M in total for 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.

Salary45%Stock awards21%Non-equity incentive33%All other compensation1%

Named executive officers

ExecutiveTotal
Thomas McCourtChief Executive Officer$1,948,390
Gregory MartiniSenior Vice President, Chief Financial Officer$1,211,133
Tammi GaskinsSenior Vice President, Chief Commercial Officer$1,215,389

What changed and why

  • $1.9MThomas McCourt received total compensation of $1,948,390 in 2025 compared to $6,083,631 in 2024.
  • Gregory Martini and Tammi Gaskins were newly designated executive officers in 2025.
  • 96%The previous say-on-pay advisory vote received approximately 96% support from stockholders.

About this page

Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.